| Document Date: 2013-09-07 08:07:36
Open Document File Size: 465,98 KBShare Result on Facebook
City Miami / San Antonio / Vienna / London / / Company Getty Images / Pharmaceutical Press / Needham / Colorcon Inc. / Table 1 Pharmaceutical / J. Pharm / Colorcon Modulation / Modified Release Technologies / The Dow Chemical Company / / Country Jordan / Austria / United States / United Kingdom / / Currency PTE / / IndustryTerm food effect / basic media / niche applications / hydrophilic matrix applications / manufacturing / aqueous solutions / aqueous solution / matrix applications / weight/volume aqueous solution / versatile extended release technology / The chemical substitution specification / chemical substituent groups / acidic media / hydrophilic matrix systems / chemical interaction / / MedicalTreatment Drug Carrier / / MusicAlbum Combinations / / Organization Controlled Release Society / American Association of Pharmaceutical Scientists Annual / / Person Abhijit Gothoskar / Kurt Fegely / Ali R. Rajabi-Siahboomi / Don Farrall / Viena Diaz / Sandip B. Tiwari / / / Position Manager / formulation scientist / researcher / General / Director Global Technical / Manager / New Product Development / / Product venlafaxine / Verapamil hydrochloride / propranolol hydrochloride / divalproex sodium / FS / metoprolol tartrate / Venlafaxine hydrochloride / nifedipine / / ProvinceOrState Indiana / / Technology Drug Delivery / API / versatile extended release technology / / URL www.uspnf.com / www.dow.com / www.colorcon.com / /
SocialTag |
Extended release Improving formulation of HPMC matrices